TopAbstracts in Hepatitis C 05/06/2003

Vaccination News Home Page Scandals subscribe Vaccination NewsLetter

http://www.inboxrobot.com/news.php3?fid=23284674

TopAbstracts in Hepatitis C 05/06/2003

05/06/2003

TopAbstracts™ in Hepatitis C are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 14 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 14 days

Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C - (J Clin Gastroenterol)
Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications - (J Psychiatr Pract)
Immunological predictors of different responses to combination therapy with interferon and ribavirin in patients with chronic hepatitis C - (J Gastroenterol)
Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia - (Antiviral Ther)
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-center case-control study - (Blood)

TopAbstracts - Past 3 months

Sexual transmission of Hepatitis C virus - (Acta Gastroenterol Latinoam)
Hepatotoxicity of Antiretroviral Therapy - (AIDS Rev)
Hepatitis C virus and arthritis - (Rheum Dis Clin North Am)
Antiviral Drugs in the Immunocompetent Host: Part I. Treatment of Hepatitis, Cytomegalovirus, and Herpes Infections - (Am Fam Physician)
Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load - (J Gastroenterol)

E-Mail this item to a colleague

To print, use this version

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.